Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium is a research paper published in Journal of Clinical Oncology (2022). On theSindex it has a DataRank of 1.1. It has been cited 50 times, with 36 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.590
From this paper's citation signal
Citation Network Contribution
0.560
From 20 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 36 citers.
NCI NIH HHS
Grant: U01 CA195603
NHLBI NIH HHS
Grant: 75N92021D00002
NHLBI NIH HHS
Grant: 75N92021D00001
World Health Organization
Grant: 001
WHI NIH HHS
Grant: 75N92021D00003
WHI NIH HHS
Grant: 75N92021D00005
WHI NIH HHS
Grant: 75N92021D00004
National Institutes of Health
Grant: 1U01CA202979-01
Southern Community Cohort Study
National Health and Medical Research Council (NHMRC)
Grant: 209057
Epidemiology of Chronic Disease, Health Interventions and DNA Studies
National Institutes of Health
Grant: 5U01CA195603-02
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
National Health and Medical Research Council (NHMRC)
Grant: 1074383
Linking lifestyle and molecular biology to inform "Precision Public Health" for major cancers
National Health and Medical Research Council (NHMRC)
Grant: 396414
The Health 2020 Cohort Study (Health 2020)
FWCI
7.93
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals